# Safety and Efficacy of Galantamine in Patients With Dementia With Lewy Bodies

> **NCT00230997** · PHASE3 · COMPLETED · sponsor: **Neurological Research Center** · enrollment: 50 (—)

## Conditions studied

- Lewy Body Disease

## Interventions

- **DRUG:** Galantamine

## Key facts

- **NCT ID:** NCT00230997
- **Lead sponsor:** Neurological Research Center
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** —
- **Final completion:** 2004-08
- **Target enrollment:** 50 (—)
- **Last updated:** 2005-12-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00230997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00230997, "Safety and Efficacy of Galantamine in Patients With Dementia With Lewy Bodies". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00230997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*